Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Topline data from phase III PATENCY-1 study of investigational vonapanitase in patients with CKD

Dec. 14, 2016

Blisibimod BRIGHT-SC study demonstrates positive trends in the week 48 analysis

Dec. 9, 2016

Regulus unveils new drug development candidates

Dec. 9, 2016

Anti-APRIL monoclonal antibody developed at Visterra for IgA nephropathy

Dec. 7, 2016

Pharmalink's Nefecon earns orphan drug designation in E.U. for IgAN

Nov. 30, 2016

MonoSol files NDA with FDA for Tadalafil PharmFilm in the treatment of erectile dysfunction

Nov. 29, 2016

Enrollment completed in phase IIa study of Serodus' SER-150

Nov. 28, 2016

RGC upregulation may have a pathogenic role in lupus nephritis

Nov. 24, 2016

Rayaldee set for U.S. launch

Nov. 24, 2016

LPA receptor 1 as a target for diabetic nephropathy

Nov. 24, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.